Resource

Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group.

Colhoun, H M
Diabetologia; 2009 Sep;52(9):1755-65. PMID: 19603149
Biomedical Research Institute, University of Dundee, Mackenzie Building, Kirsty Semple Way, Dundee, DD2 4BF, Scotland, UK. h.colhoun@cpse.dundee.ac.uk
Category: 

Abstract

The aim of the present study was to examine whether patients with diabetes in Scotland using insulin glargine have a greater cancer risk than patients using other types of insulin.